Dentsply Sirona (XRAY) Cash & Equivalents (2009 - 2026)

Dentsply Sirona has reported Cash & Equivalents for 18 years, with the latest figure at $190.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 52.26% year-over-year to $190.0 million; the trailing twelve-month figure through Mar 2026 stood at $190.0 million (down 52.26% YoY), and the FY2025 full-year result was $326.0 million, up 19.85% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $190.0 million, down from $326.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $418.0 million in Q3 2022, with the low at $190.0 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $326.4 million across 5 years, with a median of $326.0 million in 2025.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 48.75% — and 2026, when it plunged 52.26%.
• Dentsply Sirona's Cash & Equivalents stood at $365.0 million in 2022, then decreased by 8.49% to $334.0 million in 2023, then decreased by 18.56% to $272.0 million in 2024, then rose by 19.85% to $326.0 million in 2025, then plunged by 41.72% to $190.0 million in 2026.
• The last three Cash & Equivalents figures came in at $190.0 million (Q1 2026), $326.0 million (Q4 2025), and $363.0 million (Q3 2025), per Business Quant data.